Dyne Therapeutics Inc.

01/10/2025 | Press release | Distributed by Public on 01/10/2025 05:30

Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.